---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-104993"
form_type: "8-K"
ticker: "SONM"
cik: "0001178697"
company_name: "DNA X, Inc."
filed_at: "2022-04-14T23:59:59+00:00"
generated_at: "2026-06-26T07:17:24.985282+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Sonim enters $17.5M subscription agreement with AJP; Peter Liu appointed CEO

## Summary
- AJP to buy 20.8M shares at $0.84/share for $17.5M; post-transaction AJP owns ~52%.
- Peter Liu appointed CEO effective April 14, 2022; he is part of AJP investment group.
- First closing of $12.5M for 14.9M shares requires stockholder approval; second closing of $5M later.
- Board reconstituted with AJP designees; Robert Tirva to resign at first closing with $1M severance.
- Strategy shift: expand into semi-rugged and industrial 5G markets using ODM relationships.

## SEC filing metadata
- accession: 0001193125-22-104993
- form_type: 8-K
- ticker: SONM
- cik: 0001178697
- company_name: DNA X, Inc.
- filed_at: 2022-04-14T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1178697/000119312522104993/0001193125-22-104993-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1178697/000119312522104993/d325458d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-104993
- JSON: https://secwatch.observer/filing/0001193125-22-104993.json
- Plain text: https://secwatch.observer/filing/0001193125-22-104993.txt

## Key facts
- Executive change
  Robert Tirva was terminated as President, Chief Financial Officer and Chief Operating Officer at DNA X, Inc..
  - Action: terminated
  - Role: President, Chief Financial Officer and Chief Operating Officer
  source text: On April 13, 2022, the Compensation Committee of the Board of Directors of the Company approved a letter agreement with Robert Tirva, the Company’s President, Chief Financial Officer and Chief Operating Officer. The agreement provides that Mr. Tirva’s employment with the Company will terminate on, and subject to, the First Closing and that upon such termination, Mr. Tirva would be entitled to receive
  evidence_url: https://www.sec.gov/Archives/edgar/data/1178697/000119312522104993/0001193125-22-104993-index.htm
- Executive change
  Peter Liu was appointed as Chief Executive Officer at DNA X, Inc..
  - Action: appointed
  - Role: Chief Executive Officer
  source text: on April 13, 2022, the board of directors of Sonim appointed Peter Liu as Chief Executive Officer of the Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/1178697/000119312522104993/0001193125-22-104993-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.